Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Abelacimab vs Dalteparin for Blood Clot Prevention in Cancer Patients
Recruiting2 awardsPhase 3
Ottawa, Ontario
This trial will compare the effectiveness of two drugs for preventing blood clots in cancer patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.